MORF4L2 (mortality factor 4 like 2)

2008-07-01  

Identity

HGNC
LOCATION
Xq22.2
LOCUSID
ALIAS
MORFL2,MRGX
FUSION GENES

Other Information

Locus ID:

NCBI: 9643
MIM: 300409
HGNC: 16849
Ensembl: ENSG00000123562

Variants:

dbSNP: 9643
ClinVar: 9643
TCGA: ENSG00000123562
COSMIC: MORF4L2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000123562ENST00000360458Q15014
ENSG00000123562ENST00000418819Q5JXX2
ENSG00000123562ENST00000422154Q15014
ENSG00000123562ENST00000422355Q5JXX6
ENSG00000123562ENST00000423833A0A0A0MT59
ENSG00000123562ENST00000433176Q15014
ENSG00000123562ENST00000434230Q5JXX2
ENSG00000123562ENST00000441076Q15014
ENSG00000123562ENST00000442614Q5JXX1
ENSG00000123562ENST00000451301Q15014

Expression (GTEx)

0
100
200
300
400
500
600
700

Pathways

PathwaySourceExternal ID
Chromatin organizationREACTOMER-HSA-4839726
Chromatin modifying enzymesREACTOMER-HSA-3247509
HATs acetylate histonesREACTOMER-HSA-3214847

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
359008392022miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2.5
359008392022miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2.5
330112232020Identification of hub genes in unstable atherosclerotic plaque by conjoint analysis of bioinformatics.5
330112232020Identification of hub genes in unstable atherosclerotic plaque by conjoint analysis of bioinformatics.5
257966272015Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.10
257966272015Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.10
185938932008Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors.6
185938932008Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors.6
145062502003MRGX is a novel transcriptional regulator that exhibits activation or repression of the B-myb promoter in a cell type-dependent manner.11
145062502003MRGX is a novel transcriptional regulator that exhibits activation or repression of the B-myb promoter in a cell type-dependent manner.11

Citation

Dessen P

MORF4L2 (mortality factor 4 like 2)

Atlas Genet Cytogenet Oncol Haematol. 2008-07-01

Online version: http://atlasgeneticsoncology.org/gene/50257/cancer-prone-explorer/css/template-nav.css